LLC355
N/A
Report date: 2024/05/21 17:47:46
NME
Base Information
Drug NameLLC355
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity of Chinese Academy of SciencesShanghai Institute Of Organic Chemistry, Chinese Academy Of SciencesJinan University +[5]
China Registration ClassN/A
Develop Information
Active CompaniesUniversity of Chinese Academy of SciencesLivzon Pharmaceutical Group IncShanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences +[5]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A